Peter Campochiaro, MD
Disclosures: Consulting Fee-Aerpio Therapeutics|Consulting Fee-Allergan|Consulting Fee-Applied Genetic Technologies|Consulting Fee-AsclipiX|Consulting Fee-Genentech, Inc.|Consulting Fee-Rxi|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Allegro|Contracted Research-Regenxbio-Principal_Investigator|Contracted Research-Allergan-Principal_Investigator|Contracted Research-Aerpio Therapeutics-Principal_Investigator|Contracted Research-Genentech, Inc.-Principal_Investigator|Contracted Research-Genzyme Corporation-Principal_Investigator|Contracted Research-Oxford BioMedica-Principal_Investigator|Regeneron-Principal_Investigator|Consulting Fee-Exonate|Consulting Fee-Novartis AG|Contracted Research-AsclipiX-Principal_Investigator|Consulting Fee-Graybug|Ownership Interest-Graybug|Contracted Research-Clearside-Principal_Investigator
No Bio Available.